FGF2 and FGF19, seem to be involved in maintaining cancer stem-like cells (CSCs) with CD44High/CD133High cell membrane markers, which play a central role in the tumor microenvironment, potentially enhancing HCC tumorigenesis, metastasis, and anticancer drug resistance [23]. This evidence concerns the gene FGF2 and hepatocellular carcinoma.